Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | CDK1 | P06493 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30177573 | 1.00 | GAA (0.48) | GAACDK1MAPTTP53GLA | |
| SCHEMBL14366604 | 0.86 | GAA (0.54) | GAACDK1MAPTTP53GLA | |
| SCHEMBL3679455 | 0.85 | GAA (0.53) | GAACDK1MAPTTP53GLA | |
| SCHEMBL8097780 | 0.82 | GAA (0.50) | GAACDK1MAPTTP53GLA | |
| SCHEMBL9888415 | 0.81 | GAA (0.47) | GAACDK1MAPTTP53GLA | |
| SCHEMBL6571681 | 0.80 | GAA (0.48) | GAACDK1MAPTTP53GLA | |
| SCHEMBL7456515 | 0.79 | GAA (0.53) | GAACDK1MAPTTP53GLA | |
| SCHEMBL15427726 | 0.79 | GAA (0.47) | GAACDK1MAPTTP53GLA | |
| SCHEMBL28422175 | 0.79 | GAA (0.47) | GAACDK1MAPTTP53GLA | |
| SCHEMBL8539298 | 0.79 | GAA (0.51) | GAACDK1MAPTTP53GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3236749-B1 | LIQUID TRIBENURON-CONTAINING HERBICIDAL COMPOSITIONS | MITSUI AGRISCIENCE INT S A /N V (IE) | 2019-07-03 | — | — | EP | disclosed |
| EP-2144879-B1 | PYRIDON CARBOXAMIDES, AGENTS CONTAINING THESE BUT NOT IMPACTING USEFUL PLANTS AND METHOD FOR THEIR MANUFACTURE AND APPLICATION | BAYER IP GMBH (DE) | 2015-04-08 | — | — | EP | disclosed |
| US-8198214-B2 | Solid formulation | BAYER CROPSCIENCE AG (DE) | 2012-06-12 | — | — | US | disclosed |
| EP-1987718-A1 | Utilisation of pyridine-2-oxy-3-carbon amides as safener | Bayer CropScience AG (DE) | 2008-11-05 | — | — | EP | disclosed |
| EP-1987717-A1 | Pyridon carboxamides, agents containing these but not impacting useful plants and method for their manufacture and application | Bayer CropScience AG (DE) | 2008-11-05 | — | — | EP | disclosed |
| US-20070066487-A1 | Solid formulation | BAYER CROPSCIENCE GMBH (DE) | 2007-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070066487-A1 | Solid formulation | SMS, SRM, STS | GAA 1622/4885CDK1 2814/4885MAPT 3265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.